123 related articles for article (PubMed ID: 19153181)
1. Evaluation of the potential of hexamethylenetetramine, compared with tirapazamine, as a combined agent with {gamma}-irradiation and cisplatin treatment in vivo.
Masunaga S; Tano K; Watanabe M; Kashino G; Suzuki M; Kinashi Y; Ono K; Nakamura J
Br J Radiol; 2009 May; 82(977):392-400. PubMed ID: 19153181
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of a continuous administration of tirapazamine combined with reduced dose-rate irradiation using {gamma}-rays or reactor thermal neutrons.
Masunaga S; Sakurai Y; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Nagasawa H; Uto Y; Hori H; Ono K
Br J Radiol; 2006 Dec; 79(948):991-8. PubMed ID: 16916808
[TBL] [Abstract][Full Text] [Related]
3. Change in oxygenation status in intratumour total and quiescent cells following gamma-ray irradiation, tirapazamine administration, cisplatin injection and bleomycin treatment.
Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y
Br J Radiol; 2000 Sep; 73(873):978-86. PubMed ID: 11064652
[TBL] [Abstract][Full Text] [Related]
4. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
Masunaga S; Ono K; Nishimura Y; Kanamori S; Saga T; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y; Hori H
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):799-807. PubMed ID: 10837967
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
Masunaga S; Ono K; Takahashi A; Ohnishi K; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Nagasawa H; Uto Y; Hori H
Cancer Sci; 2003 Jan; 94(1):125-33. PubMed ID: 12708486
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.
Masunaga S; Nagasawa H; Uto Y; Hori H; Suzuki M; Nagata K; Kinashi Y; Ono K
Int J Hyperthermia; 2005 Jun; 21(4):305-18. PubMed ID: 16019857
[TBL] [Abstract][Full Text] [Related]
8. Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments.
Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y
Radiat Med; 1999; 17(4):259-64. PubMed ID: 10510897
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells.
Masunaga SI; Ono K; Suzuki M; Kinashi Y; Takagaki M; Hori H; Kasai S; Nagasawa H; Uto Y
Jpn J Cancer Res; 2000 May; 91(5):566-72. PubMed ID: 10835503
[TBL] [Abstract][Full Text] [Related]
10. Dependency of the effect of a vascular disrupting agent on sensitivity to tirapazamine and gamma-ray irradiation upon the timing of its administration and tumor size, with reference to the effect on intratumor quiescent cells.
Masunaga S; Nagasawa H; Nagata K; Suzuki M; Uto Y; Hori H; Kinashi Y; Ono K
J Cancer Res Clin Oncol; 2007 Jan; 133(1):47-55. PubMed ID: 16924543
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells.
Masunaga SI; Ono K; Suzuki M; Nishimura Y; Kinashi Y; Takagaki M; Hori H; Nagasawa H; Uto Y; Tsuchiya I; Sadahiro S; Murayama C
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1063-72. PubMed ID: 11429234
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.
Masunaga SI; Ono K; Kirihata M; Takagaki M; Sakurai Y; Kinashi Y; Kobayashi T; Nagasawa H; Uto Y; Hori H
Jpn J Cancer Res; 2001 Sep; 92(9):996-1007. PubMed ID: 11572769
[TBL] [Abstract][Full Text] [Related]
14. Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells.
Masunaga S; Nagasawa H; Uto Y; Hori H; Ohnishi K; Takahashi A; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Ono K
Oncol Rep; 2005 Aug; 14(2):393-400. PubMed ID: 16012721
[TBL] [Abstract][Full Text] [Related]
15. Modification of tirapazamine-induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: reference to effect on quiescent tumour cells.
Masunaga S; Ono K; Hori H; Kinashi Y; Suzuki M; Takagaki M; Kasai S; Nagasawa H; Uto Y
Int J Hyperthermia; 1999; 15(1):7-16. PubMed ID: 10193753
[TBL] [Abstract][Full Text] [Related]
16. Applicability of combination with tirapazamine in boron neutron capture therapy.
Masunaga S; Ono K; Sakurai Y; Hori H; Kobayashi T; Takagaki M; Suzuki M; Kinashi Y; Akaboshi M
Jpn J Cancer Res; 1998 Jul; 89(7):768-74. PubMed ID: 9738984
[TBL] [Abstract][Full Text] [Related]
17. Changes in the sensitivity of intratumor cells during fractionated tirapazamine administration.
Masunaga S; Ono K; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y; Hori H
Jpn J Cancer Res; 2000 Jul; 91(7):731-6. PubMed ID: 10920281
[TBL] [Abstract][Full Text] [Related]
18. Alteration of sensitivity of intratumor quiescent and total cells to gamma-rays following thermal neutron irradiation with or without 10B-compound.
Masunaga S; Ono K; Suzuki M; Sakurai Y; Kobayashi T; Takagaki M; Kinashi Y; Akaboshi M
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):653-9. PubMed ID: 10701745
[TBL] [Abstract][Full Text] [Related]
19. Effects of bioreductive agents, tirapazamine and mitomycin C, on quiescent cell populations in solid tumors, evaluated by micronucleus assay.
Masunaga S; Ono K; Hori H; Shibata T; Suzuki M; Kinashi Y; Takagaki M; Akaboshi M
Jpn J Cancer Res; 1997 Sep; 88(9):907-14. PubMed ID: 9369940
[TBL] [Abstract][Full Text] [Related]
20. Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia.
Masunaga S; Ono K; Suzuki M; Takagaki M; Sakurai Y; Kobayashi T; Akuta K; Akaboshi M; Kinashi Y; Abe M
Br J Radiol; 1997 Apr; 70(832):391-8. PubMed ID: 9166076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
